We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Surgical Decompression Reduces Cerebral Edema in Stroke

By HospiMedica International staff writers
Posted on 24 Apr 2012
Surgical decompression following acute ischemic stroke resulted in significant reduction of death or severe disability one year after recovery, according to a new study.

Researchers at the Saint Louis University School of Medicine (MO, USA) searched the Cochrane Stroke Group's Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1966-2010), EMBASE (1980-2010) and the Science Citation Index for studies that examined the effects of decompressive surgery in patients with massive acute ischemic stroke complicated with cerebral edema, as compared to medical treatment alone. More...
Main outcome measures were death at the end of follow-up, death or disability defined as over 3 on the modified Rankin Scale (mRS) at the end of follow-up, death or severe disability defined as mRS over 4 at 12 months, and disability defined as mRS 4 or 5 at 12 months.

The results showed that surgical decompression reduced the risk of death at the end of follow-up and the risk of death or disability (mRS > 4) at 12 months. Death or disability defined as mRS over 3 at the end of follow-up was no different between the treatment arms. Among the 134 adults included in three studies, two studies used a time window from stroke onset of 30 hours to decompression, and 96 hours in the third study. All patients were 60 years of age or younger, and all trials were stopped early. The study was published in the first quarter 2012 issue of the Cochrane Database of Systemic Revues.

“While decompression improves survival and the combined outcome of death and severe disability, the effects on functional outcome are not proven and the patient may survive with significant disability,” concluded lead author Salvador Cruz-Flores, MD, and colleagues of the department of neurology and psychiatry. “The implications for quality of life should be considered when considering this intervention.”

Related Links:

Saint Louis University School of Medicine




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Resorbable Bovine Collagen Membrane
GenDerm
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.